103 related articles for article (PubMed ID: 16401314)
1. Examining the relationships between the Pro12Ala variant in PPARG and Type 2 diabetes-related traits in UK samples.
Zeggini E; Parkinson JR; Halford S; Owen KR; Walker M; Hitman GA; Levy JC; Sampson MJ; Frayling TM; Hattersley AT; McCarthy MI
Diabet Med; 2005 Dec; 22(12):1696-700. PubMed ID: 16401314
[TBL] [Abstract][Full Text] [Related]
2. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
Black MH; Wu J; Takayanagi M; Wang N; Taylor KD; Haritunians T; Trigo E; Lawrence JM; Watanabe RM; Buchanan TA; Xiang AH
J Clin Endocrinol Metab; 2015 Mar; 100(3):1187-95. PubMed ID: 25584717
[TBL] [Abstract][Full Text] [Related]
3. Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes.
Stefański A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Moleda P; Pilarska K
J Hum Hypertens; 2006 Sep; 20(9):684-92. PubMed ID: 16625233
[TBL] [Abstract][Full Text] [Related]
4. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes.
Doney ASF; Fischer B; Cecil JE; Boylan K; McGuigan FE; Ralston SH; Morris AD; Palmer CNA
Diabetologia; 2004 Mar; 47(3):555-558. PubMed ID: 14730381
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population.
Wang F; Han XY; Ren Q; Zhang XY; Han LC; Luo YY; Zhou XH; Ji LN
Chin Med J (Engl); 2009 Oct; 122(20):2477-82. PubMed ID: 20079163
[TBL] [Abstract][Full Text] [Related]
6. The Pro12Ala polymorphism of PPARgamma2 gene and susceptibility to type 2 diabetes mellitus in a Polish population.
Malecki MT; Frey J; Klupa T; Skupien J; Walus M; Mlynarski W; Sieradzki J
Diabetes Res Clin Pract; 2003 Nov; 62(2):105-11. PubMed ID: 14581147
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between the Pro12Ala polymorphism of the PPAR-gamma 2 gene and type 2 diabetes mellitus in the Qatari consanguineous population.
Badii R; Bener A; Zirie M; Al-Rikabi A; Simsek M; Al-Hamaq AO; Ghoussaini M; Froguel P; Wareham NJ
Acta Diabetol; 2008 Mar; 45(1):15-21. PubMed ID: 17805473
[TBL] [Abstract][Full Text] [Related]
8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
[TBL] [Abstract][Full Text] [Related]
9. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
Vaccaro O; Lapice E; Monticelli A; Giacchetti M; Castaldo I; Galasso R; Pinelli M; Donnarumma G; Rivellese AA; Cocozza S; Riccardi G
Diabetes Care; 2007 May; 30(5):1156-61. PubMed ID: 17259473
[TBL] [Abstract][Full Text] [Related]
10. Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study.
Lamri A; Abi Khalil C; Jaziri R; Velho G; Lantieri O; Vol S; Froguel P; Balkau B; Marre M; Fumeron F
Int J Obes (Lond); 2012 Feb; 36(2):218-24. PubMed ID: 21540831
[TBL] [Abstract][Full Text] [Related]
11. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 Oct; 17(100):361-4. PubMed ID: 15690702
[TBL] [Abstract][Full Text] [Related]
12. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
[TBL] [Abstract][Full Text] [Related]
13. Comment: studies of the Pro12Ala polymorphism of the PPAR-gamma gene in the Danish MONICA cohort: homozygosity of the Ala allele confers a decreased risk of the insulin resistance syndrome.
Frederiksen L; Brødbaek K; Fenger M; Jørgensen T; Borch-Johnsen K; Madsbad S; Urhammer SA
J Clin Endocrinol Metab; 2002 Aug; 87(8):3989-92. PubMed ID: 12161548
[TBL] [Abstract][Full Text] [Related]
14. The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study.
Jaziri R; Lobbens S; Aubert R; Péan F; Lahmidi S; Vaxillaire M; Porchay I; Bellili N; Tichet J; Balkau B; Froguel P; Marre M; Fumeron F;
Diabetes; 2006 Apr; 55(4):1157-62. PubMed ID: 16567542
[TBL] [Abstract][Full Text] [Related]
15. The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado.
Nelson TL; Fingerlin TE; Moss L; Barmada MM; Ferrell RE; Norris JM
Ann Nutr Metab; 2007; 51(3):252-7. PubMed ID: 17587797
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study.
Doney AS; Fischer B; Leese G; Morris AD; Palmer CN
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2403-7. PubMed ID: 15486307
[TBL] [Abstract][Full Text] [Related]
17. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
[TBL] [Abstract][Full Text] [Related]
18. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
19. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.
Florez JC; Jablonski KA; Sun MW; Bayley N; Kahn SE; Shamoon H; Hamman RF; Knowler WC; Nathan DM; Altshuler D;
J Clin Endocrinol Metab; 2007 Apr; 92(4):1502-9. PubMed ID: 17213274
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes.
Stene LC; Thorsby PM; Berg JP; Rønningen KS; Joner G;
Pediatr Diabetes; 2008 Feb; 9(1):40-5. PubMed ID: 18211635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
